Integer Holds a Strong Presence in Medical Device Innovations
Integer Showcases Innovations at MD&M West 2025
Integer Holdings Corporation (NYSE: ITGR), a prominent player in the medical device development and manufacturing sector, will actively participate in MD&M West. Scheduled from February 4 to February 6, 2025, this event takes place at the Anaheim Convention Center, uniting key industry figures and pioneers in medical technology.
Visitors are invited to booth #1439, where Integer aims to demonstrate its unwavering commitment to providing exceptional customer partnership in delivering cutting-edge solutions for patient care. The focus will be on introducing advancements that enhance patient outcomes through innovative technologies and reliable manufacturing practices.
Highlighting Advanced Capabilities
Medical Device Solutions
Integer's exhibit promise to unveil a wealth of solutions tailored for various medical applications, including cardiology and neuromodulation. By combining cutting-edge technology with their in-depth industry knowledge, Integer empowers medical device companies to elevate their innovative projects.
Rapid Prototyping Services
Specific highlights include Integer’s global rapid prototyping services. These offerings ensure customers have direct access to a dedicated team of research and development experts, enabling speedy prototype creation with lead times as short as two weeks. This service caters to specialized areas, including structural heart and neurovascular markets, providing essential components like catheter shafts and guidewires.
Strategic Growth Through Acquisition
Integer will also utilize MD&M West to spotlight its strategic acquisition of Precision Coating, which occurred recently. This acquisition underscores Integer’s commitment to evolving in a landscape driven by technological advancements and customer needs. Precision Coating specializes in surface coating technologies, with the transaction finalized for $152 million, integrating unique coating capabilities into Integer’s existing portfolio.
“Our ongoing investments in capabilities and capacity are crucial,” stated Payman Khales, President of the Cardio and Vascular division. He emphasized that understanding and responding to customer needs in a quickly changing medical device market is vital for success.
Product Showcase at MD&M West
Throughout the event, Integer will present several key product offerings:
- Technological innovation in cardiac rhythm management, featuring compact technology for implantable pulse generators and state-of-the-art battery solutions.
- A complete suite of cardio and vascular offerings, which includes advanced electrophysiology systems and an array of high-performance catheters and guidewires.
Collaboration with Pulse Technologies
Attendees can also explore advancements at the Pulse Technologies booth, another branch of Integer, located at booth #2854. Pulse Technologies specializes in high-precision HSR technology and intricate micro machining essential for critical medical device components.
Looking Ahead with Integer
Integer will share insights related to the Precision Coating acquisition during its upcoming fourth-quarter earnings call, scheduled for February 20, 2025. Interested stakeholders should stay tuned for valuable updates on the company’s performance and strategic directions.
For more information on Integer and their offerings, please visit www.integer.net.
Frequently Asked Questions
What is Integer Holdings Corporation's main focus?
Integer Holdings Corporation specializes in developing and manufacturing medical device solutions, focusing on enhancing patient care through innovative technologies.
Where is Integer showcasing its products?
Integer will exhibit its products at MD&M West 2025, located at booth #1439 in the Anaheim Convention Center.
What new acquisition did Integer announce?
Integer recently acquired Precision Coating, enhancing its service offerings with specialized surface coating technologies.
What services does Integer provide regarding rapid prototyping?
Integer offers global rapid prototyping services, allowing for quick turnaround times using dedicated research and development expertise aimed at specialized cardiovascular markets.
When will Integer discuss the Precision Coating acquisition in detail?
Details about the acquisition will be discussed during Integer's fourth-quarter earnings call on February 20, 2025.
About The Author
Contact Dominic Sanders privately here. Or send an email with ATTN: Dominic Sanders as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
